Dunn A, Macfarlane A
National Perinatal Epidemiology Unit, Radcliffe Infirmary, Oxford.
Arch Dis Child Fetal Neonatal Ed. 1996 Jul;75(1):F10-9. doi: 10.1136/fn.75.1.f10.
To review trends in multiple births and associated mortality in England and Wales since 1975, in the light of trends for earlier years; to assess, within the limitations of the available data, the extent of any association between multiple birth rates and assisted conception and drugs used for subfertility.
Data collected routinely in England and Wales, between 1975 and 1994, were retrospectively reviewed. These comprised Office of Population Censuses and Surveys (OPCS) data collected at the registration of live and stillbirths and deaths occurring under the age of 1 year in England and Wales from 1975 onwards. Department of Health data about NHS prescriptions dispensed outside hospitals within England for drugs which could be used in the medical management of subfertility were also included.
The proportion of pregnancies that resulted in a registered multiple birth increased from a low of 9.9 per thousand in 1975 to 13.6 per thousand in 1994. Up to 1992, the increase was seen in all age groups except for women under 20, with the most substantial increase being in women aged 35 to 39. The rise in the rate of triplet and other higher order births was much steeper than that for all multiple births, increasing from 0.13 sets of triplets per thousand maternities in 1975, to 0.41 in 1994. Prescriptions dispensed for selected drugs that may be used for the medical management of subfertility and assisted conception became more common over this period. The fragmented nature of the data precluded direct comparison with changes in multiple birth rates, however.
Although the causes of the rise since 1980 in multiple birth rates in general, and the dramatic rise in the triplet rate in particular, cannot be ascertained or quantified directly from routinely collected data, drugs used for subfertility and more recently, assisted conception, probably had a major role.
根据早年的趋势,回顾1975年以来英格兰和威尔士多胎生育及相关死亡率的趋势;在现有数据的局限性范围内,评估多胎出生率与辅助受孕及用于治疗不育症的药物之间的关联程度。
对1975年至1994年期间在英格兰和威尔士常规收集的数据进行回顾性分析。这些数据包括人口普查与调查办公室(OPCS)从1975年起收集的英格兰和威尔士活产、死产及1岁以下死亡登记数据。还纳入了卫生部关于在英格兰医院外配给的可用于不育症药物治疗的国民保健服务(NHS)处方数据。
登记的多胎妊娠比例从1975年的每千例9.9例的低点上升至1994年的每千例13.6例。到1992年,除20岁以下女性外,所有年龄组均出现增长,35至39岁女性增长最为显著。三胞胎及其他高阶多胎出生率的上升幅度远高于所有多胎出生率,从1975年每千例产妇中有0.13例三胞胎增至1994年的0.41例。在此期间,用于不育症药物治疗和辅助受孕的特定药物处方变得更为普遍。然而,数据的分散性使得无法直接与多胎出生率的变化进行比较。
尽管无法从常规收集的数据中直接确定或量化1980年以来多胎出生率总体上升的原因,尤其是三胞胎出生率急剧上升的原因,但用于不育症治疗的药物以及最近的辅助受孕药物可能起到了主要作用。